Use of an inhibitor of factor (alpha) amp; amp; tumor necrosis as an antihistamine for the treatment of allergic rhinitis and allergic conjunctivitis.

摘要

Methods are described for the treatment of patients with allergic conjunctivitis and allergic rhinitis that include topical administration of a composition comprising a pharmaceutically effective amount of an H1 antagonist and a TNFa (alpha) blocking compound.